|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: KERYX BIOPHARMACEUTICALS INC, 10-Q, 2000-11-14 |
Next: ARISTOTLE INTERNATIONAL INC, RW, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
unaudited interim consolidated financial statements at September 30, 2000 and
for the six month period then ended, and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 50,349,477
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 50,897,591
<PP&E> 243,463
<DEPRECIATION> 25,742
<TOTAL-ASSETS> 51,914,553
<CURRENT-LIABILITIES> 475,796
<BONDS> 0
0
0
<COMMON> 19,440
<OTHER-SE> 51,231,884
<TOTAL-LIABILITY-AND-EQUITY> 51,914,553
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> (8,372,470)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (8,372,470)
<INCOME-TAX> (93,000)
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (8,465,470)
<EPS-BASIC> (0.79)
<EPS-DILUTED> (0.79)
</TABLE>
|
|